Good Lifestyle

Many of us have never been expectedCovid lasts more than a year And certainly, do not want it to last another. Fortunately, the United States already has two targeted Covid vaccines to stop the propagation of coronavirus. Moderna and Pfizer started distributing their vaccines in December, and more are probably on the vaccine at a glance at Johnson & Johnson. Although all this seems to be good news, health leaders are being frank about how they expect the future of the pandemic to play, and it may not be exactly what you want to hear. In fact, CEO Johnson & Johnson has just predicted a rather disturbing prediction about Covid. Continue reading for his thoughts on where we go from here and for more predictions about the future,Dr. Fauci just said that we will never be able to do that again.

Even if Johnson & Johnson has created a dose vaccine, it does not mean that it's a hit, then you're done forever. During the 9th of February interview with CNBC, CEO of Johnson & JohnsonAlex Gorsky indicated that the coronavirus behind Covid-19 can be somethingWe are dealing with beyond this year.

"I think most people think it will be something that will be likely that, yes, the coming years we will get a photo of Covid-19, just as if we would be a shot of the flu," said Gorsky. "Exactly what this shot is going to be composed, I do not think we know today. But I think we could all imagine a future where we live with that, but where we can keep science at the rhythm of the virus." And for more information on vaccine deployment,You can be vaccinated at any Walgreens on this date.

According to Gorsky, "a lot of things will depend on what is happening with this virus", especially with regard to how it develops into new variants. Currently, disease control and prevention centers (CDC) have identifiedThree new more communicable variants This was done in the United States: a variant of the U.K., A variant of South Africa and a variant of Brazil.

"You know, unfortunately, as [Covid] also spreads it can also mutated. And every time it mutes, it is almost like another clic of the dial, in order to speak, where we can see another variant, a Another mutation, which can have an impact on its ability, for example, to repel antibodies or have a different type of response, not only to a therapeutic, but also to a vaccine, "said Gorsky. And for more on the return to normality,This COVID restriction could last years, say experts.

In particular, the southern Africa variant B.1.351, has already shown resistance to COVID vaccines. According toThe New York Times, Just south africastopped using the AstraZeneca-Oxford vaccine In their country, because the researchers determined that it did not prevent people from developing moderate infections. Other vaccines, such as Moderna's, Pfizer's and Johnson & Johnson, still seem to be effective against this strain, but less than with earlier variants, which raises concerns for how future mutations can escape these vaccines. more.

"It becomes more and more obvious that we are going to be blocked in this reality-mole play, where we have variants that do not respond to vaccines"Andrea Taylor, PhD, Deputy Director of the Global Center for Innovation Global Health, saidThe New York Times. "We will try to change vaccines to target new variants, but the virus will still be able to spread in some populations in some parts of the world, other variants will appear." And for more information up to date,Sign up for our daily newsletter.

In terms of modification of vaccines, moderna and pfizer have already begunWork on potential reminderTreat with emerging variants. Johnson & Johnson recently submitted data for their dose vaccine to the US Food and Drug Administration (FDA) for an emergency authorization, which will face a vote on February 26. However, as the future of the pandemic is uncertain, the same goes for the future of Johnson & Johnson's vaccine. The manufacturer is currently testing a second dose of the vaccine.

Mathai Mammen, MD, World Research and Development Manager at Janssen Pharmaceutical companies in Johnson & Johnson,Said during an interview of January 5th that the company was preparing forTest participants on a level at two doses, giving two doses of the vaccine spaced two months apart. "The reason we execute this second study is to see if a second dose can provide superior or longer protection," says Mammen.

As Gorsky explained later, after testing their dose vaccine in Hotspot variant locations such as Brazil and South Africa, Johnson & Johnson realized that emerging variants are something that the Manufacturer must "prepare in the coming years", which can call this second dose in use. And for the essential guidance of the vaccine,If this happens after your vaccine, the FDA says you should call 911.